This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novo Nordisks monlunabant showed signs of neuropsychiatric sideeffects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity.
By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. The post SideEffects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?
Graphite Bio voluntarily paused a Phase 1/2 test of its gene-edited therapy for sickle cell disease after the first patient in the study developed a serious blood complication. The setback will also delay plans to reach the clinic with another genetic medicine in its pipeline.
For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the sideeffects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.
Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many sideeffects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease.
Acquiring Bellus Health gives GSK a drug for recurrent chronic cough that could offer a better sideeffect profile compared to a Merck drug that addresses the same target. Bayer was also pursuing the target, but stopped work on its drug candidate last year.
The deal gives the pharmaceutical giant a small molecule that could provide an alternative to a class of drugs that introduce dangerous sideeffects. Merck is acquiring Imago BioSciences, a clinical-stage biotech whose lead drug is in development for myelofibrosis and other blood cancers.
Liver complications are a known sideeffect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.
Rapport Therapeutics’ lead program could offer more targeted epilepsy treatment compared to currently available anti-seizure medications, which introduce many sideeffects. The IPO will support plans to develop the oral small molecule in focal epilepsy as well as chronic pain and bipolar disorder.
The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better sideeffect profile. AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications.
The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over. The most common sideeffects observed were initial insomnia, irritability and dyskinesia. It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain.
billion buyout of Principia Biopharma has run into trouble, after the FDA placed it on partial clinical hold while a safety signal is investigated. One of the main assets of Sanofi’s $3.7 The hold on dosing applies to subjects in the trials who have received the drug for less than 60 days.
The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months. .
The Swiss biotech is seeking a priority review for vamorolone, which was licensed from US biotech ReveraGen BioPharma in 2020 after Santhera its former DMD therapy candidate idebenone failed clinical testing and was abandoned.
Biopharma Akeso Inc. state the therapy could help reduce sideeffects and safety concerns. has announced it will enter into a collaboration potentially worth up to $5 billion with Summit Therapeutics Inc., Under the agreement, Akeso Inc. will receive a $500 million upfront payment.
billion buyout of Principia Biopharma. That could give the drugs an advantage over CD20-targeting therapies like Roche’s Ocrevus (ocrelizumab) that inhibit B cells across the board, leaving patients prone to infections and other sideeffects.
In recent years, the biopharma market has become progressively complex. Payers must take into consideration not only the clinical efficacy of a drug, but also its safety profile, sideeffects, and cost-effectiveness, among other factors.
billion deal, in which Eli Lilly agreed to acquire two of POINT Biopharma Global’s late-stage radioligand therapies for oncological indications. One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the sideeffects that are commonly experienced with chemotherapy.
Myovant Sciences has rejected an acquisition offer from Sumitovant Biopharma and its wholly owned subsidiary, Sumitomo Pharma. Most currently available therapeutic options for endometriosis often have a diminished efficacy over time and result in negative sideeffects such as menopausal-like sideeffects and bone mineral density (BMD) loss.
A recombinant form of IL-2 has been used as a therapeutic for melanoma and renal cell carcinoma for many years under the Proleukin (aldesleukin) trade name, originally by Novartis and latterly by Clinigen, but while effective its use has been limited due to serious sideeffects. billion.
As we enter into the age of precision medicine, AI will be a critical tool to determine, with the help of disease knowledge graphs, which indications, associations, contraindications, sideeffects, genetic markers, drug targets, drug carriers, and interactions to take into account on a case-by-case basis.
DANNY SIGURDSON CEO and Founder Courier Health To effectively engage patients and prescribers to improve overall adherence to prescribed medication regimens, biopharma companies first need the visibility and full context of where a patient stands in their treatment journey. Patients’ challenges are diverse.
Speciality pharmacies play a crucial role in medication dosing, disease and sideeffects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.
She stated that some of the key concerns were around viral safety, immunogenicity and the fact that long term sideeffects are unknown. For cell and gene therapy, a “big issue” she stated, was the complexity of manufacturing. For these therapies, Warner highlighted their short shelf life and scale up.
.” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative sideeffects. Over 6,000 industry leaders, scientists, engineers, physicians, and investors will be attending for the 21st consecutive year of this conference.
Our clinical data is encouraging and supports potential registrational paths based upon its molecular design focused upon selectivity for cancer-relevant T cells and decreased sideeffects. What Is Your Company Currently Working On?
Preference data can also be used to help make strategic decisions internally — for example, knowing patient preferences for the mode of administration or avoidance of sideeffects may help with clinical trial endpoint selection or product development.
Recall from the earlier section that one of the primary roles of a rare disease sales force is not just education on the product and its efficacy, sideeffects, etc., but, unlike most products with larger patient populations, education on the rare disease itself and its diagnosis.
Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and sideeffects).
What sideeffects should you contact a doctor about immediately, or what are the risks of a procedure and the likelihood of success? We chose the most common diseases within each therapy area, so that there was more information available and answering the questions that the patients [wanted] answered.
Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. These topics might include sideeffect management, patient compliance, and needs for other resources such as mental healthcare, general wellness, etc.
Fox says adjuvant protein subunit vaccines can be a safer approach compared to live attenuated virus vaccines as there is a minimized risk of developing sideeffects. GC Biopharma is also running a Phase III trial for its live-attenuated vaccine GC-3107A to replace BCG.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content